Terms: = Skin cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Prognosis
104 results:
1. Functional assay for assessment of pathogenicity of BAP1 variants.
Repo PE; Backlund MP; Kivelä TT; Turunen JA
Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
[TBL] [Abstract] [Full Text] [Related]
2. iris melanoma: Review of clinical features, risks, management, and outcomes.
Cherkas E; Kalafatis NE; Marous MR; Shields CL
Clin Dermatol; 2024; 42(1):62-70. PubMed ID: 37865279
[TBL] [Abstract] [Full Text] [Related]
3. BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma.
Zhang C; Wu S
Mol Med; 2023 Sep; 29(1):126. PubMed ID: 37710185
[TBL] [Abstract] [Full Text] [Related]
4. Omission of Completion Lymph Node Dissection in Sentinel Node Biopsy Positive Head and Neck Cutaneous Melanoma Patients.
Kesmodel SB; Kronenfeld JP; Zhao W; Koru-Sengul T; Goel N; Weingrad DN; Hernandez-Aya L; Lutzky J; Feun L; Garland-Kledzik M; Crystal JS
Ann Surg Oncol; 2023 Nov; 30(12):7671-7685. PubMed ID: 37639029
[TBL] [Abstract] [Full Text] [Related]
5. iris melanoma: Prognostication for metastasis.
Melendez-Moreno A; Yeşiltaş YS; Wrenn J; Singh AD
Surv Ophthalmol; 2023; 68(5):957-963. PubMed ID: 37207703
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup.
Patuzzo R; Mattavelli I; Gallino G; Galeone C; Valeri B; Mocellin S; Del Fiore P; Ribero S; Mandalà M; Tauceri F; Lombardo M; Maurichi A;
Cancer; 2023 Aug; 129(15):2331-2340. PubMed ID: 37162404
[TBL] [Abstract] [Full Text] [Related]
7. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.
Bălăşoiu AT; Ştefănescu-Dima AŞ; Bălăşoiu M; Ciurea RN; Muraru A; Dan AO; Simionescu CE
Rom J Morphol Embryol; 2022; 63(4):645-652. PubMed ID: 36808200
[TBL] [Abstract] [Full Text] [Related]
8. Relationship between Fitzpatrick skin Type and The cancer Genome Atlas Classification with Melanoma-Related Metastasis and Death in 854 Patients at a Single Ocular Oncology Center.
Sen M; Card KR; Caudill GB; Spitofsky NR; Dockery PW; Zaloga AR; Zeiger JS; DeYoung CF; Hamou SJ; Shields CL
Ophthalmic Genet; 2022 Dec; 43(6):742-755. PubMed ID: 36369870
[TBL] [Abstract] [Full Text] [Related]
9. Pan-cancer analysis of the prognostic and immunological role of brca1-associated protein 1 gene (BAP1): Friend or foe?
Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
[TBL] [Abstract] [Full Text] [Related]
10. CTLA4 , PD-1 , PD-L1 , PD-L2 , TIM-3 , TIGIT , and LAG3 DNA Methylation Is Associated With BAP1 -Aberrancy, Transcriptional Activity, and Overall Survival in Uveal Melanoma.
de Vos L; Carrillo Cano TM; Zarbl R; Klümper N; Ralser DJ; Franzen A; Herr E; Gabrielpillai J; Vogt TJ; Dietrich J; Strieth S; Landsberg J; Dietrich D
J Immunother; 2022 Sep; 45(7):324-334. PubMed ID: 35862127
[TBL] [Abstract] [Full Text] [Related]
11. S1 Guidelines for the Kaposi Sarcoma.
Esser S; Schöfer H; Hoffmann C; Claßen J; Kreuter A; Leiter U; Oette M; Becker JC; Ziemer M; Mosthaf F; Sirokay J; Ugurel S; Potthoff A; Helbig D; Bierhoff E; Schulz TF; Brockmeyer NH; Grabbe S
J Dtsch Dermatol Ges; 2022 Jun; 20(6):892-904. PubMed ID: 35657085
[TBL] [Abstract] [Full Text] [Related]
12. In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations.
Piaggio F; Croce M; Reggiani F; Monti P; Bernardi C; Ambrosio M; Banelli B; Dogrusöz M; Jockers R; Bordo D; Puzone R; Viaggi S; Coviello D; Lanza FB; Bartolucci M; Petretto A; Mosci C; Gangemi R; van der Velden PA; Jager MJ; Pfeffer U; Amaro A
Eur J Cancer; 2022 Jul; 170():27-41. PubMed ID: 35580369
[TBL] [Abstract] [Full Text] [Related]
13. Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated Cell Adhesion Molecules in Uveal Melanoma.
Baqai U; Purwin TJ; Bechtel N; Chua V; Han A; Hartsough EJ; Kuznetsoff JN; Harbour JW; Aplin AE
Mol Cancer Res; 2022 Aug; 20(8):1260-1271. PubMed ID: 35426938
[TBL] [Abstract] [Full Text] [Related]
14. The long-term prognosis of patients with untreated primary uveal melanoma: A systematic review and meta-analysis.
Stålhammar G; Gill VT
Crit Rev Oncol Hematol; 2022 Apr; 172():103652. PubMed ID: 35304261
[TBL] [Abstract] [Full Text] [Related]
15. The unfolded protein response and the biology of uveal melanoma.
Zhang S; Wang K; Zhu X; Cherepanoff S; Conway RM; Madigan MC; Zhu L; Murray M; Zhou F
Biochimie; 2022 Jun; 197():9-18. PubMed ID: 35093452
[TBL] [Abstract] [Full Text] [Related]
16. ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine.
Xu J; Su SM; Zhang X; Chan UI; Adhav R; Shu X; Liu J; Li J; Mo L; Wang Y; An T; Lei JH; Miao K; Deng CX; Xu X
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35025764
[TBL] [Abstract] [Full Text] [Related]
17. Case Series: Different Presentations of iris Melanoma-Potential Masquerade of Benign and Malignant.
Allen N; Misra SL; McGhee CNJ; Crawford AZ
Optom Vis Sci; 2022 Mar; 99(3):298-302. PubMed ID: 34923538
[TBL] [Abstract] [Full Text] [Related]
18. No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter.
Sabazade S; Herrspiegel C; Gill V; Stålhammar G
BMC Cancer; 2021 Nov; 21(1):1270. PubMed ID: 34819035
[TBL] [Abstract] [Full Text] [Related]
19. Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light iris versus Dark iris Color.
Wierenga APA; Brouwer NJ; Gelmi MC; Verdijk RM; Stern MH; Bas Z; Malkani K; van Duinen SG; Ganguly A; Kroes WGM; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
Ophthalmology; 2022 Apr; 129(4):421-430. PubMed ID: 34780841
[TBL] [Abstract] [Full Text] [Related]
20. Merkel cell polyomavirus-negative Merkel cell carcinoma is associated with JAK-STAT and MEK-ERK pathway activation.
Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Kohashi K; Kuwamoto S; Umekita Y; Oda Y
Cancer Sci; 2022 Jan; 113(1):251-260. PubMed ID: 34724284
[TBL] [Abstract] [Full Text] [Related]
[Next]
